New drugs in Brazil: Do they meet Brazilian public health needs?
Objetivos. Describir los nuevos medicamentos lanzados al mercado en Brasil durante el per\uedodo 2000\u962004, comparar su descripci\uf3n con la carga de enfermedades del pa\ueds y recomendar iniciativas que permitan enfrentar la situaci\uf3n desde la ...
Flores Vidotti, Carlos Cezar
core
Nurse performance in hospital financial auditing: a single case study. [PDF]
Meneguin SH, Nogueira VDSN, Bocchi SCM.
europepmc +1 more source
[Transphobia in Brazil in the context of the pandemic: perceptions and actions of political groups that defend the trans population]. [PDF]
Diniz AM, Silva VLMD.
europepmc +1 more source
Variability in public procurement prices for Group 1A drugs in the specialized pharmaceutical component: an observational study, 2013-2022. [PDF]
Rossignoli P +2 more
europepmc +1 more source
[Agreement on pandemics and access to vaccines for low- and middle-income countriesAcuerdo sobre el acceso a las vacunas durante las pandemias para los países de ingresos bajos y medianos]. [PDF]
de Abreu AJL, Ventura DFL, Waldman EA.
europepmc +1 more source
Antimicrobial sales profile in Brazil from 2014 to 2021: analysis of records from the National System of Controlled Products Management. [PDF]
Barbosa JR +5 more
europepmc +1 more source
Analysis of the post-incorporation period of health technologies incorporated into the SUS, from 2012 to 2022. [PDF]
Schneider NB, Etges APBDS, Polanczyk CA.
europepmc +1 more source
Mobile Emergency Care Service: direct costs for personnel, materials, medications and solutions. [PDF]
Nascimento LMLD, Lima AFC.
europepmc +1 more source
[The role of regulatory agencies within health systems during emergencies in BrazilPapel de los organismos regulatorios en los sistemas de salud en situaciones de emergencia en Brasil]. [PDF]
Pepe VLE +2 more
europepmc +1 more source
C3 Glomerulopathy: recent advances and an update on management. [PDF]
Palma LMP, Barbosa MINH, Sethi S.
europepmc +1 more source

